Startup

Fondation Innovative Medicines for Tuberculosis (iM4TB)

Description

The Fondation Innovative Medicines for Tuberculosis (iM4TB) is a non-profit organization based at EPFL dedicated to developing better and faster-acting medicines to combat all forms of tuberculosis. With a team of experienced researchers, iM4TB focuses on finding new molecules that can effectively kill the TB bacterium without harming patients. The foundation has received significant funding, including a grant from the Bill & Melinda Gates Foundation, to support the development of their innovative anti-tuberculosis drug PBTZ169. iM4TB's mission is crucial in the global fight against tuberculosis, a disease that claims the lives of three individuals every minute worldwide.

Official source
About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.